文献速递医学教育与科研方法真实世界研究与卫生经济

希望使者、研究先锋与变革推动者:个体参与创新健康技术随机试验的期望与体验——纵向定性研究

Ambassadors of hope, research pioneers and agents of change-individuals' expectations and experiences of taking part in a randomised trial of an innovative health technology: longitudinal qualitative study.
PubMed 文献 · Trials · 2019-05-27

该纵向定性研究访谈了24名参与闭环系统随机试验的1型糖尿病患者,分别在随机分组后和试验结束时进行访谈。参与者描述了利他与自利动机常不可分割的复杂议程,并因支持可能改变生活的技术而付出额外努力管理糖尿病。作者认为解读试验结果需考虑参与者的理解与动机,并提出「利他自利议程」新概念。

要点

  • 参与者参与试验的利他与自利考虑常不可分割,形成复杂议程。
  • 参与者因支持创新技术而更专注于糖尿病管理以优化闭环效果。
  • 作者建议解读试验结果时考虑参与者的理解与动机。

核心结论

  • 作者认为,为辅助解读试验结果,需考虑参与者对参与试验的理解与动机。
  • 作者建议在文献中引入新概念「利他自利议程」,以认识自利与利他动机的潜在不可分割性。

研究设计与样本

  • 纵向定性研究,访谈24名参与闭环系统随机试验的1型糖尿病患者,分别在随机分组后和试验结束时进行访谈。

主要发现

  • 参与者提供了复杂的参与议程,其中利他与自利考虑常不可分割。
  • 许多参与者描述属于更广泛的糖尿病社群,并受益于他人参与研究,由此产生公民义务感。
  • 参与者对贡献于研究感到兴奋和自豪,将自己视为希望使者和研究先锋。
  • 随访时参与者描述在试验期间付出了额外努力,更专注于糖尿病管理以帮助创造闭环系统最有效工作的条件。

临床怎么用

  • 作者建议在解读试验结果时考虑参与者的理解与动机。
  • 作者建议引入「利他自利议程」概念以认识自利与利他动机的潜在不可分割性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While a growing body of research has explored why people take part in clinical trials, this research has not considered how people's understandings, motivations and agendas might influence their conduct during a trial. This is an important area of enquiry because it is now widely recognised that an intervention might lead to different clinical outcomes when delivered as part of a trial than when implemented in routine clinical practice; however, the reasons for this are not fully understood. METHODS/DESIGN: We interviewed 24 individuals who took part in a trial of an innovative health technology under development for people with type 1 diabetes which automatically regulates blood glucose: the closed-loop system. Participants were interviewed following randomisation to a closed-loop and at trial closeout. RESULTS: Participants provided complex agendas for taking part in which altruistic and self-interested considerations were often inseparable. Many described belonging to a wider diabetes community and being beneficiaries of others' participation in research and how this had given rise to attendant citizenship obligations. Participants also shared the excitement and pride they experienced from contributing to research which situated them at the forefront of technological innovation and enabled them to present themselves to others, by virtue of their trial participation, as ambassadors of hope and research pioneers. Given their desire to support the progression of a potentially life-changing technology, and be part of that innovation, participants, at follow-up, described having made extra effort during the trial. Specifically, participants described having been more focused on their diabetes management to help create conditions in which the closed-loop could work most effectively to optimize their blood glucose control. CONCLUSIONS: Our findings contribute a new dimension to understandings of trial effects; specifically, we argue that, to aid interpretation of trial outcomes, participants' understandings and motivations for participation need to be considered. We highlight the potential pertinence of our findings in the contemporary era of bio-citizenship where, increasingly, people are driving research agendas and see themselves as co-producers of knowledge. We also recommend a new concept be introduced into the literature-'the altruselfish agenda'-to recognise potential inseparability of self-interested and altruistic motivations. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02523131 . Registered on 14 August 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lawton J, Blackburn M, Breckenridge JP, et al. Ambassadors of hope, research pioneers and agents of change-individuals' expectations and experiences of taking part in a randomised trial of an innovative health technology: longitudinal qualitative study. Trials. 2019. PMID: 31133076. doi:10.1186/s13063-019-3373-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。